Your browser doesn't support javascript.
loading
Corrigendum to 'Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study' [J Hepatol 67 (2017) 940-949].
Bureau, Christophe; Adebayo, Danielle; Chalret de Rieu, Mael; Elkrief, Laure; Valla, Dominique; Peck-Radosavljevic, Markus; McCune, Anne; Vargas, Victor; Simon-Talero, Macarena; Cordoba, Juan; Angeli, Paolo; Rosi, Silvia; MacDonald, Stewart; Malago, Massimo; Stepanova, Maria; Younossi, Zobair M; Trepte, Claudia; Watson, Randall; Borisenko, Oleg; Sun, Sun; Inhaber, Neil; Jalan, Rajiv.
Afiliação
  • Bureau C; Service d'hépato-gastroentérologie, CHU Toulouse, Toulouse, France.
  • Adebayo D; UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom.
  • Chalret de Rieu M; Service d'hépato-gastroentérologie, CHU Toulouse, Toulouse, France.
  • Elkrief L; DHU UNITY, Service d'hépatologie, Hôpital Beaujon, Clichy and Université Paris Diderot and Inserm U1149, Paris, France.
  • Valla D; DHU UNITY, Service d'hépatologie, Hôpital Beaujon, Clichy and Université Paris Diderot and Inserm U1149, Paris, France.
  • Peck-Radosavljevic M; Department of Gastroenterology/Hepatology, Endocrinology and Nephrology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
  • McCune A; Department of Hepatology, Bristol Royal Infirmary, Bristol, United Kingdom.
  • Vargas V; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
  • Simon-Talero M; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
  • Cordoba J; Liver Unit, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, VHIR, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.
  • Angeli P; Facoltà di Medicina e Chirurgia, Università degli Studi di Padova, Padova, Italy.
  • Rosi S; Facoltà di Medicina e Chirurgia, Università degli Studi di Padova, Padova, Italy.
  • MacDonald S; UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom.
  • Malago M; Hepato-pancreatic-biliary and Liver Transplantation Surgery, Royal Free Hospital, University College London, London, United Kingdom.
  • Stepanova M; Center for Outcomes Research in Liver Disease, Washington DC.
  • Younossi ZM; Department of Medicine, Inova Fairfax Hospital, Falls Church, VA.
  • Trepte C; Sequana Medical AG, Zurich, Switzerland.
  • Watson R; Medicalwriters.com, Zurich, Switzerland.
  • Borisenko O; Synergus AB, Danderyd, Sweden.
  • Sun S; Synergus AB, Danderyd, Sweden; Health Outcomes and Economic Evaluation Research Group, Department of Learning, Information, Management and Ethics, Karolinska Institutet, Stockholm, Sweden and Division of Epidemiology and Global Health, Department of Public Health and Clinical Medicine, Umeå Universi
  • Inhaber N; Sequana Medical AG, Zurich, Switzerland.
  • Jalan R; UCL Institute of Hepatology, Royal Free Hospital, University College London, London, United Kingdom. Electronic address: r.jalan@ucl.ac.uk.
J Hepatol ; 72(3): 595-596, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31928862
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article